1. DeGraaf, G. L., Pals, D. T., Couch, S. J., and Lawson, J. A., Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.J. Pharmacol. Exp. Ther., 264, 6–10 (1993).
2. Gardes, J., Gonzalez, M. F., Alhenc Gelas, F., and Menard, J., Influence of sodium diet on L-NAME effects on renin release and renal vasoconstriction.Am. J. Physiol., 267, F798–804 (1994).
3. Guan, H., Cachofeiro, V., Pucci, M. L., Kaminski, P. M., Wolin, M. S., and Nasjletti, A., Nitric oxide and the depressor response to angiotensin blockade in hypertension.Hypertension, 27, 19–24 (1996).
4. Haber, E., Koerner, T., Page, L. B., Kliman, B., and Purnode, A., Application of a radioimmunoassay for angiotensin 1 to the physiologic measurements of plasma renin activity in normal human subjects.J. Clin. Endocrinol. Metab., 29, 1349–1355 (1969).
5. Haberl, R. L., Decker, P. J., and Einhaupl, K. M., Angiotensin degradation products mediate endothelium-dependent dilation of the rabbit brain arterioles.Circ. Res., 68, 1621–1627 (1991).